Dr. Iris Zippora Ahronowitz, MD

Dr. Ahronowitz practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Ahronowitz's NPI, 1437445632, was assigned on June 26, 2011. Dr. Ahronowitz graduated from UCSF School of Medicine in 2011. Dr. Ahronowitz holds California license A123269.

Dr. Ahronowitz's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Ahronowitz's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Ahronowitz to 3 more group practices and clinics, 2 medical groups and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ahronowitz practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ahronowitz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ahronowitz is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Ahronowitz's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Ahronowitz treats.

CMS data shows 339 Medicare services from Dr. Ahronowitz across 7 procedure codes in 2024, for 120 Medicare patients. Medicare paid $14,699 for them. Every service was in an office.

CMS counts 120 Medicare patients who saw Dr. Ahronowitz in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ahronowitz's median patient age at 55, with 61% women.

In 2024, Dr. Ahronowitz wrote 368 Medicare Part D claims for 111 patients. 80% of them were for generic drugs. CMS names the drug for 269 of them, across 10 drugs with 11 or more claims each, at $242,780 in total drug cost. In 2023, CMS named 689 claims across 20 drugs.

Dr. Ahronowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ahronowitz as offering telehealth. CMS counts 291 procedures of removal of skin lesions by Dr. Ahronowitz, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Ahronowitz, published from 2008 to 2022. The most frequent topics are Polymorphism, Genetic and Skin Neoplasms. Dr. Ahronowitz's most frequent co-authors are David C. Choi, MD, Lindy P. Fox, MD and Joanna Harp, MD.

CMS Open Payments shows 2 general payments to Dr. Ahronowitz from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $22.

Dmand AI lists 1 award for Dr. Ahronowitz, most recently AOA Inductee 2011 in 2011.

Dr. Ahronowitz graduated from UCSF School of Medicine in 2011. Dr. Ahronowitz is a member of AOA.

Dr. Ahronowitz is in network with 11 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.